Phosphatases are important enzymes in a variety of biochemical pathways in different cells which they catalyze opposing reactions of phosphorylation and dephosphorylation, which may modulate the function of crucial signaling proteins in different cells. This is an important mechanism in the regulation of intracellular signal transduction pathways in many cells. Phosphatases play a key role in regulating signal transduction. It is known that phosphatases are specific for cleavage of either serine-threonine or tyrosine phosphate groups. To date, numerous compounds have been identified. This paper reviews the classification, roles and pharmacological of protein serine/threonine phosphates.
A large number of physiological functions, such as cell signalling, gene expression and mitosis are influenced by phosphorylation/de-phosphorylation events (1) (2) (3) . This crucial regulatory process is controlled by two key enzymes, protein kinases, that transfer phosphate from ATP to the protein (phosphorylation) and protein phosphatases, that catalyse the reverse reaction (dephosphorylation). It is thought that over 30% of all cellular proteins are subject to phosphorylation at one or more residues. Eukaryotic cells have been approximated to possess 2% of the genome and of the order of 150 protein phosphatases (4) .
Understanding the role of protein phosphatases in these systems has lagged noticeably behind that of protein kinases. Indeed, until recently, protein phosphatases were regarded as relatively nonspecific, unsophisticated enzymes that existed only to reverse the action of protein kinases. The main function of phosphatases is to de-activate enzymes by removing activating phosphate groups that are often present as a result of induced kinase activity. However, to view phosphatases simply as molecular "off switches" is a gross oversimplification of their intracellular role(s) .
In the past decade there has been a considerable increase in attempts to clarify the biological roles of protein phosphatases, and their potential importance in the context of health and disease. Protein phosphatases that dephosphorylate either tyrosine or serine and threonine constitute the two main families and are referred to as protein tyrosine phosphatases (pTPs) and protein serine/threonine phosphatases (PPs), respectively. Each class will be discussed in turn.
phosphorylation is a well-established mechanism for cellular regulation in eukaryotic cells. Many PTPs in animals are expressed in a tissue-specific or developmental stage-specific manner, and their expression levels are often modulated by environmental conditions (5) .
The level of tyrosine phosphorylation in normal cells is determined by the balanced activity of PTKs and PTPs. There are predicted to be approximately 100 PTPs encoded within the human genome. Based on phosphoamino acid specificity, PTPs can be divided into two large groups: tyrosine-specific PTPs and dual-specificity PTP (DsPTPs). Tyrosinespecific PTPs dephosphorylate phosphotyrosine but not phosphoserine/threonine, whereas the DsPTPs dephosphorylate both (6) . The tyrosinespecific PTPs can be further categorized into transmembrane receptor-like and the intracellular or non-transmembrane PTPs. The receptor-like PTPs generally have an extracellular putative ligandbinding domain, a single transmembrane region, and one or two cytoplasmic PTP domains. The intracellular PTPs, exemplified by PTP IBand SHP I, contain a single catalytic domain and various amino or carboxyl terminal extensions including SH2 domains that have targeting or regulatory functions. Although the overall protein sequences of tyrosinespecific PTPs and DsPTPs share little homology, they all contain a signature motifin the catalytic core: (V/I)HCXAGXGR(S/T)G that harbours a cysteinyl residue that is essential for catalytic activity.
Protein serine/threonine phosphatases (PPs)
Traditionally, the PPs that catalyse the dephosphorylation of serine and threonine residues have been categorized into four subtypes based on their biological characteristics, sensitivities to specific inhibitors, and substrate specificity. These are PPI, PP2A, PP2B (also known as calcineurin), and PP2C. The primary amino acid sequences ofPP I, PP2A, and PP2B are similar, with PPI and PP2A sharing 43% sequence identity overall whereas PP2C is structurally distinct and belongs to a completely different gene family. Other phosphatases have been identified consisting ofPP4, PP5, PP6, and PP7. PP4 and PP6 are structurally related to PP2A, sharing 65 and 57% amino acid homology. PP4 is 45% identical to PP I, but only in its catalytic domains. PP5 contains a catalytic domain common to PPI, PP2A, PP2B, PP4 and PP6 family of enzymes and an extended N-terminal domain containing four 34-amino acids repeats motifs. PP7 consists of a catalytic core domain similar to the other phosphatases, but has unique Nand C-terminal regions and shares < 35% identity with other known protein phosphatases. In spite of this broad range of protein phosphatases, most of the phosphatase activity within the cell is attributable to PPI and PP2A.
Protein serine/threonine phosphatase] (PPl)
PPI is a significant eukaryotic protein serine/ threonine phosphatase that regulates a huge variety of cellular functions via the interaction of its catalytic subunit (PPlc, 37kDa) with over fifty different established or putative regulatory subunits (7) . Eukaryotic genomes contain one to eight genes encoding PPI isoforms. Regulation of PPlc in response to extracellular and intracellular signals takes place mostly through changes in the levels, conformation or phosphorylation conditions of targeting subunits. There are four mammalian PPI isoforms PPla, PPlP (or <», PPlyl and PPlyz encoded by three genes with human isoforms being highly homologous and exhibiting greater than 90% identity (8) . Moreover, all four PPI subtypes appear to be well-conserved, sharing approximately 80% and 60% identity with yeast and plant homologues, respectively (9) ( Table I) .
Regulation ofPP]
The activity ofPPI is tightly regulated in vitro by interaction of the catalytic subunit with endogenous regulatory subunits and inhibitory proteins. The catalytic subunits of PP I do not exist freely in the cell, but they associate with a host of different regulatory proteins to form a variety of distinct multimeric holoenzymes. Regulators of PPI can be divided into primary and secondary regulators (7) , according to whether they originated as regulators or acquired this PP I binding function only later in evolution. These interactions are critically important in regulating PPI activity and targeting PPI to discrete sub-cellular locations.
An important consequence of interactions of PPI with proteins and targeting subunits relates to substrate specificity. The catalytic subunit of PP I (PPlc) is involved in the dephosphorylation of multiple substrates that have no obvious sequence specificity. This wide substrate specificity of PP 1 appears to be governed by the action of regulatory subunits that possess the ability to target the catalytic subunit to specific intracellular locations (10) .
Many endogenous proteins such as three heatstable inhibitor proteins, inhibitor 1, inhibitor 2, and dopamine and cAMP regulated phosphoprotein ofM, 32000 (DARP-32) have been shown to interact with PPl, leading to substantial changes in localization and activity. Moreover, a wide range of targeting proteins, can recruit phosphatases into signalling complexes (7) .
The regulation of PP 1 by regulatory proteins and targeting subunits is illustrated quite effectively by considering glycogen metabolism. A variety ofPP 1ctargeting subunits can target the enzyme to glycogen of which the glycogen targeting subunit, G sub ' is best characterized. Other subunits include G M , G L , R5 and R6, for which glycogen-targeting domains have been mapped (11) . The association between PPlc and G sub is regulated by phosphorylation of the G sub at two serine residues, both located within a phosphoregulatory domain in the amino terminus, by distinct kinase activities (12) . The activation of cyclic AMPdependent protein kinase by adrenaline stimulates the phosphorylation of the G sub and reduces the affinity of the G sub for the catalytic subunit of PPI (13) . Consequently, release of catalytic subunit to the cytosol and interaction with protein inhibitors ofPP 1, inhibitors 1 and 2 (14) , promotes the phosphorylation of glycogen synthetase, favouring the metabolism of glycogen.
Physiological andpathological roles ofPP 1
PP 1 has been implicated in the regulation of such diverse mammalian actions as glycogen metabolism, lipid metabolism, synaptic plasticity, muscle contraction, gene transcription, cell cycle progression and smooth muscle contraction (15) . PP 1 is integrally involved in the mediation of insulin action on carbohydrate and lipid metabolism. More specifically, activation of PPI accompanies insulin stimulation. Activation of PPI occurs through phosphorylation ofits glycogen association regulatory subunit. Type-2 diabetes mellitus is characterized by a variation in response to insulin and PP 1 as a molecule involved in the insulin signalling cascade is a potential target for therapeutic drug design. Furthermore, polymorphisms in the PPI glycogen targeting subunit have been associated with some forms of type 2 diabetes (16) .
PP2A
PP2A is also a major phosphatase in all eukaryotic cells and has a wide range of biological functions (17) . PP2A can exist in vivo in a dimeric (PP2A D ) or a trimeric (PP2~) form (18, 19) . The core enzyme of PP2A (PP2A D ) comprises a~36-kDa catalytic subunit (C) that is always associated with a 65-kDa scaffolding subunit, called subunit A or PR65, which modulates its enzymatic properties (20) . These two associated proteins form the core dimer that is able to interact with a third, variable subunit or other regulatory proteins (Table I) .
PP2A is present in many tissues. Distinct holoenzymes are differentially expressed and distributed in tissue and cells. PP2A is present at particularly high levels in heart, skeletal muscle brain, lung, muscle, kidney, testis and placenta (21) . The widespread distribution of this protein suggests that it functions in a number of aspects of cellular physiology.
Catalytic and regulatory subunit ofPP2A
The catalytic subunit (PP2A c) is highly conserved and shares approximately 50% primary amino acid sequence homology with PPl c The PP2A c subunit, that exists as the a and~isofonns, is encoded by two genes, whose products share 97% identity (22) . Molecular cloning ofPP2A c has revealed that PP2A c is one of the evolutionarily most conserved proteins. The identity between the human and budding yeast amino-acid sequence of PP2A c is 86% (23) . The second component of PP2A core dimer is PR65/A, which also exists as two (a and B) isofonns. PR65/A is composed of 15 tandemly linked leucine rich repeats (HEAT motifs) containing from 39 to 41 amino-acid residues (23) . The variable B subunits are classified into four families ofunrelated proteins: the (a) PR55/B family with four isofonns (a, {J, y, 15); (b) the PR56/6l/B' family encoded by five genes (a, {J, y, 15, c), some transcripts ofwhich undergo alternative splicing to generate up to eleven isofonns, and (c) the PR48/59172/130/B" family containing four proteins generated by alternative splicing of a single gene, as well as the product of a closely related gene. In mammalian cells cDNAs have been identified for two PR65/A subunits, two PR65/C subunits and over twenty B subunits (24) . This suggests the existence of numerous PP2A complexes. The many known PR/B regulatory subunits, including splice variants, theoretically could form more than 50 different trimeric holoenzymes (24) .
Regulation ofPP2A
The main regulators ofthe catalytic subunit, C, of PP2A are the regulatory A and B subunits that control PP2A activity and target holoenzymes to specific intracellular compartments. The catalytic subunit of PP2A is always associated with the scaffolding subunit, A, and this modulates the enzymatic properties of PP2A. It is now well recognized that B-type subunits act, in part, as endogenous inhibitors for PP2A and can alter functional specificity (25) . They display differential affinities for the core enzyme, and their binding to the AC dimer modulates the catalytic activity of PP2A in vitro. The extent of this effect greatly varies according to the substrate and type of subunit present in the enzymatic complex. Overexpression of B' subunits modulates endogenous PP2A activity (26) . Likewise, overexpression of mutants of A that bind to C, but not to B, leads to degradation of intracellular PP2A. Therefore, changing the ratio between endogenous levels of core enzyme and holoenzymes exerts a tremendous influence on PP2A regulation (26) . Alternative non-regulatory subunit inhibitors have also been identified such as two protein inhibitors of PP2Ac, termed IIPP2A and I/P2A (27) . These proteins are functionally similar to the inhibitor proteins that have been identified for PP 1. Phosphorylation of PP2Ac appears to be important in the regulation of catalytic activity. Phosphorylation at both threonine and tyrosine residues leads to inhibition of catalytic activity. Interestingly, regulatory B subunits prevent the dephosphorylation of phosphotyrosine by inhibiting PTPs thereby sustaining the inhibitory effects on catalytic activity (28) .
Physiological andpathological roles ofPP2A
PP2A accounts for as much as 1% of total cellular proteins and for the major protein serine/threonine phosphatase activity in most tissue and cells (17) . Biochemical and genetic studies have revealed that PP2A enzymes are remarkably conserved during evolution. The importance of PP2A in regulating physiological processes is highlighted by genedeletion studies. Deletion of the gene encoding the PP2A catalytic subunit is lethal in yeast and mouse (29) , demonstrating that PP2A is essential. PP2A controls the activities of several major protein kinase families, in particular protein kinase B (PKB), protein kinase C, p70 S6 kinase, calmodulin dependent kinase, MAP kinases and cyclin-dependent kinases (30) . Upon cell stimulation, specific kinases are transiently phosphorylated and activated. Several of these protein kinases are substrates for PP2A. This phosphatase appears to be a major kinase phosphatase in eukaryotic cells that downregulates activated protein kinases (30) . Abnormal expression, mutation or deletion of PP2A subunits are involved in cellular processes leading to tumour formation. Several mechanisms can be responsible for abnormal growth by PP2A. Over-expression of the A subunit induces the development ofmultinucleated cells (20) . . The discovery of mutations in the gene encoding the A subunit in human breast, lung and colorectal carcinomas and melanomas strengthens the notion that PP2A is involved in tumorigenesis (31) .
PP2B
PP2B is a serine/threonine protein phosphatase that is calciumicalmodulin-dependent (20) . PP2B is broadly distributed in mammalian tissues but high concentrations are found within the CNS, and PP2B has also been closely associated with cells of the immune system. PP2B was first purified from brain, where it was found in high concentration in neurons (32) . This finding, together with the calciumdependence of the phosphatase, has led the enzyme to be also known as calcineurin. Structurally, PP2B is a heterodimeric phosphatase consisting of a 60 kDa catalytic subunit, calcineurin A (CnA) and a 19 kDa high-affinity calcium-binding regulatory subunit, calcineurin B (CoB) ( Table I) .
Calcineurin A (CnA)
Biochemical and genetic studies have identified four distinct functional domains of CnA, a catalytic domain, a CoB binding domain, a calmodulin binding domain, and an auto-inhibitory domain. The catalytic domain of CnA is structurally similar to the catalytic domain ofPPI with the exception of two short insertions towards the end of the catalytic domain that may govern PP2B substrate specificity (33) . The three isoforms are expressed to different degrees in different tissues. High expression ofAfJ is found in the thymus, while both An and AfJ are found within the peripheral immune system. Differences are also observed for the expression patterns of An and AfJ within specialized tissues, such as the rat nephron, where An expression was observed to be higher in the proximal tubules than in the medullary thick ascending limbs and the cortical collecting ducts (34) .
Calcineurin B (CnB)
Calcineurin B is the regulatory subunit of calcineurin and exists as two isoforms, CnB1 and CnB2, the latter specifically found in the testis (35) . CnB has 35% sequence identity to calmodulin and contains an amino terminal myristoylated glycine and four high affinity EF-hand calcium-binding sites. The binding of calcineurin B to calcineurin A allows the enzyme to achieve a two-to three-fold increase in activity (36) . The binding of calcium-bound calmodulin to the calmodulin binding site within the carboxy terminus of CnA results in an additional tento twenty-fold increase in the phosphatase activity of the enzyme. These events induce conformational changes in CnA that allow calcineurin substrates to gain access to the catalytic site and undergo dephosphorylation (37) .
Regulation ofPP2B
The most important regulator of PP2B activity, as already mentioned, is calcium. Elevations in calcium concentration lead to activation of CnB and calmodulin and interactions of these allosteric regulators with CnA, leads to a dramatic increase in the catalytic activity of PP2B. However, other endogenous regulators ofPP2B have been identified.
A number of endogenous cellular proteins have emerged as inhibitors of PP2B activity and thus may act as potential regulators of its in vivo function (38) . One of the first to be identified was a 79-kDa protein kinase A anchoring protein (AKAP79) (39) . AKAP79 acts as a neuronal scaffold protein to localize protein kinase A (via the regulatory subunit), PKC, and PP2B at postsynaptic densities (40) . In addition, there are three modulatory calcineurin interacting proteins (MCIP; also known as the Down syndrome critical region 1) genes in humans and mice. MCIPI proteins bind directly to CnA. MCIPI is unique among the known endogenous PP2B regulators in that its transcription is activated by PP2B, establishing a potential negative feedback loop that is conserved in organisms as diverse as mammals and yeast (41) .
Physiological andpathological roles ofPP2B
A critical role for the regulation of an important group of transcription factors, referred to as Nuclear Factors of Activated T cells (NFAT), has been identified for PP2B. NFAT was originally identified in T lymphocytes but has since been shown to be expressed in alternative cells of the immune system such as B lymphocytes, mast cells and basophils (42) . NFAT is present in the cytosol in a phosphorylated form. However, if the cell is activated by stimulation of receptors that are coupled to calcium entry, then increases in intracellular calcium result and PP2B is activated (43) . PP2B dephosphorylates cytosolic NFAT and the transcription factor is now able to enter into the nucleus and increase transcription of, primarily, cytokine genes such as that for IL-2 (44, 45) . The generation of cytokines, such as IL-2, leads to promotion of an immune response. In many situations, this response may be desirable. However, inappropriate activation of PP2B/NFAT with the elaboration ofcytokines may occur in situations such as autoimmunity, psoriasis and allergic conditions (46, 47) . Targeting PP2B, in these conditions, may be beneficial and indeed, the immunosuppressants, cyclosporine and tacrolimus (FK506), act by inhibiting PP2B. Different studies indicate that PP2B may play a key role in the process of memory and learning (48) , apoptosis (49) , neuronal excitability, and cardiac hypertrophy (50) . An interesting development is that PP2B inhibitors may have potential as anti-fungal and anti-parasitic agents. PP2B is involved in the regulation of Ca 2 + pumps and exchangers responsible for Ca 2 + homeostasis in some prokaryotic organisms (51) .
PP2C
PP2C is a Mg 2 +-dependent protein phosphatase The highly conserved metal binding coordination between mamma-lian PP2C and phosphatase homologs from prokaryota . All residues shown are from Thermosynechococcus elongates; residues indicated in parentheses are from the human protein.
The binding locations for the aJ helix and the Hsp90 peptide do not overlap with each other. The two conformations of the TPR domain bound to the oJ helix or the Hsp90 peptide are markedly different from each other. that is structurally different to PP I, PP2A and PP2B and shows little homology with any known phosphatases. Despite this, PP2C displays a degree of overlapping substrate specificity particularly with PPI and PP2A (52) . Multiple isoforms, of PP2C have been recognized in humans, yeast and mice and these constitute a distinct gene family . As PP2C exists as multiple isoforms this allows for tissue specific expression (53) . PP2C isoforms are broadly expressed but most abundant in heart and skeletal muscle (54) . PP2C is insensitive to okadaic acid and other naturally-occurring protein phosphatase inhibitors and the lack of pharmacological agents able to modulate PP2C activity has hindered the understanding of its character in regulating cell function. Nevertheless, an important role for PP2C has been identified in the context of the cell cycle. PP2C has been shown to regulate negatively the cell cycle in a manner similar to that of PP 1 and PP2A via the dephosphorylation and activation of cyclindependent kinases (55) (Table I) .
Additional protein serine/threonin e phosphatases
Although PPI , PP2A, PP2B and PP2C constitute the main classes of protein phosphatase in existence, a number of additional phosphatases have been identified. These appear, largely, to be involved in regulating the cell cycle and are discussed below.
PP4
The mammalian and Drosophila PP4 sequences share 94% uniqueness, which is similar to that observed for PPI and PP2A, the most-conserved enzymes known in eukaryotic development, suggesting that PP4, like PP I and PP2A, might provide crucial functions. Like PP2A, PP4 is a holoenzyme comprised ofcatalytic (C), structural (A) and regulatory (B) subunits. The amino acid residues in the catalytic subunit of PPI, PP2A, and PP2B, that are critical for catalytic activity, are conserved in PP4 c (56) . The location ofPP4 at the centrosome, in the nucleus and weakly in the cytoplasm suggests a multiplicity of functions. An okadaic acid-sensitive phosophatase is known to play a part in initiating microtubule growth at centrosomes, and although this was originally thought to be PP2A, PP4 now appears a more likely candidate (57) .
PP5
Based on its sequence, PP5 represents a distinct phosphoprotein phosphatase subfamily, with an N-terminal domain that contains four tetratricopeptide repeat (TPR) motifs fused to a C-terminal catalytic domain. The TPR domain is thought to form a scaffold-like structure and may target PP5 to its site of action or substrate. The TPR domains also negatively regulate the activity of the catalytic domain (58) . Bacterially expressed PP5 is essentially inactive, but can be activated> 25-fold by proteolytic cleavage of the TPR domain, indicating that the activity ofthe catalytic domain is suppressed by the TPR domain (Table I) .
Human PP5 appears to participate in cell growth, because higher levels of PP5 exist in cells in logarithmic growth than in dividing or serumdeprived cells (59) .Treatmentofcells with u-amanitin at concentrations that inhibit RNA polymearase led to increased levels of PP5 in the nucleolus, suggesting a role for PP5 in the regulation of ribosomal RNA transcription (60) . More recently, PP5 was identified in glucocorticoid receptor complexes. In mammalian cells transiently transfected with the TPR domain of PP5, glucocorticoid receptor signalling was significantly reduced (58) .
PP6andPP7
Recently PP6 and PP7 have been identified using molecular cloning strategies and biochemical approaches. PP6 catalytic subunits (PP6 c) have been classified as PP2A family members based on their high homology (60-65%) amino acid sequence identity with PP2A catalytic subunit (61) . Relatively, little is known about the function and regulation of mammalian PP6 c although a recent study has revealed it is a phosphoprotein that forms a stable complex with spliceosomal small nuclear ribonucleoproteins in lymphocytes (62) . Like PP5, PP7 appears to be a member of a distinct family within the protein serine/threonine phosphatase superfamily (63) . PP7, like PP2B, is a Ca 2+ -activated protein phosphatase. Human PP7 contains two putative Ca 2+-binding EF-hands downstream of the phosphatase catalytic subdomain (64) . PP7 isolated from Arabisopsis is able to bind calmodulin in a Ca 2+-dependent manner (65) . The most relevant properties of PP7 are to thought to be localised to the nucleus.
Pharmacological regulation ofPPs
The discovery of many naturally-occurring phosphatase inhibitors, which are able to penetrate living cells, has been a breakthrough in the study of the functions of phosphatases. This has aided enormously in characterizingthe role ofphosphatases in physiological processes both in vitro and in vivo. These inhibitors can be broadly classified as those that inhibit PPIIPP2A and those that inhibit PP2B. The inhibitor IC50 values are not always directly comparable from source to source. They may vary depending on the substrate, and on the purity, concentration and origin of the purified protein
PP1IPP2A inhibitors
The best studied, and most widely used, phosphatase inhibitor in this class is okadaic acid (OA), a polyether fatty acid produced by marine dinoflagellates and causative agent of diarrhoetic shellfish poisoning (66) .
The mechanism by which naturally-occurring toxins inhibit phosphatase activity is complex and has been mostly studied in relation to PP1 and crystallographic studies (67) . Thus the cyclic heptapeptide, microcystin LR, interacts with two of the metal-bound water molecules ofPPI and thereby blocks the binding of substrates to the catalytic site (68) . OAis about ten-fold more potent as an inhibitor of PP2A than PPI. Shibata et al. noted that OA increased tone in smooth muscle preparations. OA inhibited PPl, PP2A, and PP2B with IC50 values of272, 1.6, and 3,600 nM, respectively (69) . PP2C, phosphotyrosyl phosphatase, acid phosphatase, and alkaline phosphatase were not inhibited by up to 10 mM OA. Moreover, OA in concentrations, 2 nM inhibits also PP4, PP5, and PP6 that are present in mammalian cells.
In addition, the polyether fatty acid, okadaic acid, binds to the hydrophobic groove and forms hydrogen bounds with Tyr-272 in the~12-~13 loop and with basic residues in the catalytic site of PPI (70) . Another polyether fatty acid, calyculin A(CyA), contains a phosphate group that interacts with the metal binding site. However, calyculin A forms a tight network of interactions with the hydrophilic and acidic grooves. CyA induced muscle fiber contraction and contraction of cardiac preparations. It is equally potent against PPI and PP2A, with IC50 values from 1 to 14 nM. Okadaic acid and CyA seem to compete for the same inhibitory site on PP2A (1). The antitumor antibiotic fostriecin (CI-920) is a type II DNA topoisomerase-directed anticancer drug. It is a naturally occurring compound from Streptomyces pulveraceous subspecies fostreus, an actinomycete found in a Brazilian soil sample. Fostriecin inhibited both PP1 and PP2A with IC50 values of 4 roM and 40 nM, respectively (1).
PP2B inhibitors
Several compounds are known to inhibit PP2B (calcineurin) activity in vitro and in vivo. Cyclosporin A (CsA) and tacrolimus, also known as FK506, are potent immunosuppressive agents derived from microorganisms that target PP2B. They primarily affect T-lymphocyte function, but also have suppressive effects on mast cell mediator production and release (71) .
CsA, isolated from the fungus Tolypocladium inflatum Gams, is a highly lipophilic molecule made up of 11 amino acids with a molecular weight of 1203 kDa. CsA binds to a family of cytoplasmic proteins termed immunophilins or cyclophilins, resulting in a drug receptor complex that inactivates calcineurin Calcineurin is normally activated after T-cell stimulation and is central to signal transduction events leading to cytokine production. When CsA binds to cyclophilin, it forms a complex that prevents cytokine transcription .
Tacrolimus (FK506), isolated from the fungus Streptomyces tsukabaensis, is a hydrophobic compound that consists of 3 aliphatic rings, two of which are heterocyclic with a molecular weight of 822 kDa. FK506, like CsA, also affects T cells and mast cell function by binding to cytoplasmic immunophilins. The major receptor in lymphocytes for FK506 is called immunophilin-12 (12 kDa) or FK binding protein 12 (FKBP-12) (72) . Like the CsA-cyclophilin complex, FK506 bound to FKBP-12 inhibits calcineurin activity, thus inhibiting the dephosphorylation and activation of cytoplasmic previously, NF-AT (73) . This prevents NF-AT from translocating into the nucleus and initiating cytokine transcription. FK506 also inhibits the synthesis of cytokines as well as the release of proinflammatory and vasoactive mediators from mast cells and basophils (42) . Cyclosporin A and tacrolimus in a concentration-dependent manner with IC50 values (10 and 1 nM, respectively) are consistent with their known IC50 values for inhibition ofcalcineurin (74) .
CONCLUSION
As part of the intracellular processes leading to cell activation, the phosphorylation state of key substrates is likely to be important. Phosphorylation of substrates, mediated by kinases, and dephosphorylation of substrates, mediated by phosphatases, are responsible for regulating phosphorylation. While a substantial body of evidence has emerged investigating the role of kinases in the regulation ofcell function, considerably less has been learnt about the role that phosphatases play. This is probably due to a perception that kinases and phosphorylations move processes along, whereas phosphatases and dephosphorylations terminate events and exert more of a passive role. This perception is misguided since phosphatases are now known to be active players in the control of cells, the importance of PP2B in the regulation of cytokine generation from Th cells being a case in point. Another factor that has not aided the study of phosphatases is the lack of pharmacological probes. However, the recent emergence of a wide range of naturally-occurring, cell permeant inhibitors of phosphatases has helped immeasurably in delineating the role that phosphatases play in regulating cells.
